Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DF9S1L
|
|||
| Drug Name |
ATA2271
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Mesothelioma [ICD-11: 2C51.2; ICD-10: C45; ICD-9: 163] | Phase 1 | [1] | |
| Company |
Atara Biotherapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mesothelin (MSLN) | Target Info | . | [1] |
| NetPath Pathway | TCR Signaling Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Atara Biotherapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.